UA85563C2 - Fused heterocyclic compounds - Google Patents

Fused heterocyclic compounds

Info

Publication number
UA85563C2
UA85563C2 UAA200603249A UAA200603249A UA85563C2 UA 85563 C2 UA85563 C2 UA 85563C2 UA A200603249 A UAA200603249 A UA A200603249A UA A200603249 A UAA200603249 A UA A200603249A UA 85563 C2 UA85563 C2 UA 85563C2
Authority
UA
Ukraine
Prior art keywords
heterocyclic compounds
fused heterocyclic
serotonin
pyrazole
treatment
Prior art date
Application number
UAA200603249A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Николас Л. Каррутерс
Веньинг Чаи
Сяоху Денг
Курт А. Дворак
Аннетт К. Квок
Джимми Т. Лянг
Неелаканда Мани
Дейл А. Рудольф
Виктория Д. Вонг
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of UA85563C2 publication Critical patent/UA85563C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Certain fused pyrrole- and pyrazole-containing heterocyclic compounds are serotonin modulators useful in the treatment of serotonin-mediated diseases.
UAA200603249A 2003-09-17 2004-09-15 Fused heterocyclic compounds UA85563C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50452803P 2003-09-17 2003-09-17

Publications (1)

Publication Number Publication Date
UA85563C2 true UA85563C2 (en) 2009-02-10

Family

ID=37520186

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200603249A UA85563C2 (en) 2003-09-17 2004-09-15 Fused heterocyclic compounds

Country Status (4)

Country Link
CN (3) CN101318962A (en)
CA (1) CA2782783C (en)
UA (1) UA85563C2 (en)
ZA (1) ZA200603031B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201120586D0 (en) * 2011-11-30 2012-01-11 Ge Healthcare Ltd Solid phase extraction neutralisation
US20190135834A1 (en) * 2016-04-26 2019-05-09 Shionogi & Co., Ltd. 5-substituted azabenzimidazole derivative having ???? activation action
CN108285460A (en) * 2017-01-09 2018-07-17 南京圣和药业股份有限公司 A kind of pharmaceutical salts of EGFR kinase inhibitor and preparation method thereof and purposes
MX2020006460A (en) * 2017-12-22 2020-11-06 Chemocentryx Inc DIARYL SUBSTITUTED 5,5-FUSED RING COMPOUNDS AS C5aR INHIBITORS.
CN110117284B (en) * 2018-02-06 2021-11-19 江苏奥赛康药业有限公司 Nitrogen-containing heterocyclic compound and preparation method and application thereof
CN112300169B (en) * 2019-07-26 2022-03-04 上海美迪西生物医药股份有限公司 Pyrrolopyrazole derivatives, their preparation method and their application in medicine
CN110194773B (en) * 2019-07-26 2019-11-22 上海美迪西生物医药股份有限公司 Pyrrolopyrazole derivatives, their preparation method and their application in medicine
CN112300167B (en) * 2019-07-26 2022-01-21 上海美迪西生物医药股份有限公司 Pyrrolopyrazole derivative, preparation method and medical application thereof
CN112390801A (en) * 2019-08-15 2021-02-23 上海美迪西生物医药股份有限公司 Pyrrolopyrazole derivative, preparation method and medical application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663178A (en) * 1995-02-06 1997-09-02 Eli Lilly And Company Tetrahydro-beta carbolines
TW470745B (en) * 1996-05-23 2002-01-01 Janssen Pharmaceutica Nv Hexahydro-pyrido[4,3-b]indole derivatives
EP0905136A1 (en) * 1997-09-08 1999-03-31 Janssen Pharmaceutica N.V. Tetrahydro gamma-carbolines

Also Published As

Publication number Publication date
CN101318962A (en) 2008-12-10
CN1882590B (en) 2014-03-05
CN101318961A (en) 2008-12-10
CN1882590A (en) 2006-12-20
CA2782783A1 (en) 2005-05-06
CN101318961B (en) 2012-11-28
CA2782783C (en) 2018-03-27
ZA200603031B (en) 2007-07-25

Similar Documents

Publication Publication Date Title
SG146683A1 (en) Fused heterocyclic compounds as serotonin receptor modulators
DE602004026113D1 (en) GLP-1 COMPOUNDS
SG145701A1 (en) Piperazine derivatives and their use as therapeutic agents
SG145695A1 (en) Pyridyl derivatives and their use as therapeutic agents
SG145700A1 (en) Pyridyl derivatives and their use as therapeutic agents
IL189164A0 (en) Pyrimidine compounds as serotonin receptor modulators
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
TW200801006A (en) Fused bicyclic mTOR inhibitors
NO20083002L (en) Method for using CD40 binding compounds
EA200600203A1 (en) DERIVATIVES 2- (CHINOXALIN-5-ILSULPHONYLAMINO) BENZAMIDE IN THE QUALITY OF CCK2 MODULATORS
UA85559C2 (en) Aminobenzophenone compounds
PL374401A1 (en) 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
ATE496892T1 (en) TETRAHYDROISOCINOLINE COMPOUNDS FOR THE TREATMENT OF CNS DISEASES
GB0416508D0 (en) Therapeutic agents
SI1899334T1 (en) Naphthyridine compounds
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
HRP20150163T1 (en) PROCEDURE FOR THE PRODUCTION OF N-SUBSTITUTED 2-CYANOPYROLIDINE
SE0301650D0 (en) Novel compounds
UA85563C2 (en) Fused heterocyclic compounds
EP1436279B8 (en) Chemical compounds
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
ATE281455T1 (en) OXINDOL DERIVATIVES
MY145145A (en) Fused pyrazole-containing heterocyclic compounds as serotonin receptor modulators
NO20061624L (en) Merged heterocyclic compounds
MY142798A (en) Methods for preventing glyconoylation of proteins